1. Alestrom, P., Akusjarvi, G., Pettersson, M. and Pettersson, U., 1982, DNA sequence analysis of the region encoding the terminal protein and the hypothetical N-gene product of adenovirus type 2, J. Biol. Chem., 257:13492–13498
2. Ballay, A., Levrero, M., Buendia, M.A., Tiollais, P. and Perricaudet, M., 1985, In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses, EMBO J., 4:3861–3865
3. Barr, D., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson, C., Perkins, J. and Kay, M.A., 1995, Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immuno-competent and imunodeficient inbred strains, Gene Therapy, 2:151–155
4. Berget, S.M., Moore, C. and Sharp, P.A., 1977, Spliced segments at the 5’ terminus of adenovirus 2 late mRNA, Proc.Natl.Acad.Sci.USA, 74:3171–3175
5. Bridges, S.H. and Sarver, N., 1995, Gene therapy and immune restoration for HIV disease, Lancet, 345:427–432